Summary
This K08 proposal will complete Dr. Wajd Al-Holou’s training towards his long-term career goal of directing an independent research program that aims to define critical cellular interactions in the tumor microenvironment that drive treatment resistance in glioblastoma (GBM) and ultimately identify therapies targeting mechanisms of resistance. Dr. Al-Holou is an assistant professor in the department of Neurosurgery at the University of Michigan with established success in the field of neurosurgical oncology who completed his clinical training at the University of Michigan and MD Anderson Cancer
